Key facts
- It has raised $89.2M.
- Notable investors include Bpifrance, BlackRock, b2venture, Supernova Invest, Crédit Mutuel Equity — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for UroMems
- ·The full record, as it builds
Funding rounds
No funding rounds for UroMems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About UroMems
Developer of an implantable medical device designed to focus on designing, developing, and commercializing active implantable medical devices. The company's device improves current surgical treatments for as many patients as possible, particularly by reducing associated side effects, enabling patients to find the right treatment as soon as possible.
- Sector
- Healthcare
- HQ
- Eybens, France
- Founded
- 2011
- Employees
- 65
- Website
- uromems.com/
- Ownership
- Privately Held (backing)
UroMems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in UroMems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on UroMems in its N-PORT filings yet. We sweep new filings monthly.